European Commission

Herbal medicinal product: Echinaceae purpureae herbaArray, C: ongoing call for scientific data

Retrieved on: 
Friday, February 16, 2024
Key, Allergy, European Commission, Committee, Infection, Monograph, Asteraceae, Plant, Asthma, Skin, Date, Echinacea, Mouth, Safety, Civil service commission, Common, Rash, Anaphylaxis, Patient, Medicine, Stevens–Johnson syndrome, Community, Herbal medicine, Wound healing, Medicinal plants

Herbal medicinal product: Echinaceae purpureae herbaArray, C: ongoing call for scientific data

Key Points: 


Herbal medicinal product: Echinaceae purpureae herbaArray, C: ongoing call for scientific data

Mortgage borrowing limits and house prices: evidence from a policy change in Ireland

Retrieved on: 
Friday, February 16, 2024
Diamond, Research, Person, Growth, House, GDP, Marital status, Financial integration, STB, McQuade, Section 2, Statistics, Literature, Fellow, Housing, European Systemic Risk Board, The Irish Times, R21, Lapointe, Data, Selection bias, R30, C0, Steinsson, Financial Times, International Monetary Fund, Book, Paper, European Commission, FTB, LTV, Household, Roadmap, Central Bank of Ireland, E44, Section 5, Financial crisis, Central bank, Civil service commission, European Central Bank, Network, Section 4, Section 8, Favara, Central Bank of Myanmar, Population growth, OECD, BTR, Google Trends, Consumption, Aggregation, JEL, Section 3, Government, Cell, Risk, NAMA, Policy, E21, SSB, Vertical, ECB, Real estate
Key Points: 

    Bee Vectoring Technologies Announces Trials in Spain with Agrobio SL and Funded by Major EU Initiative

    Retrieved on: 
    Thursday, February 15, 2024
    International, European Commission, IPM, Pest control, CVE, Growth, Tuta absoluta, BVT, Pollination, Climate change, Fruit, Agriculture, Integrated pest management

    Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - February 15, 2024) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce Agrobío SL commenced trials of BVT's natural precision agriculture system in December.

    Key Points: 
    • Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - February 15, 2024) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce Agrobío SL commenced trials of BVT's natural precision agriculture system in December.
    • It will foster stakeholder adoption by surveying what they currently use, what they need, and conducting trials and demonstrations of new tools with industrial partners.
    • Spain is one of the largest fruit and vegetable producers in Europe and represents the largest market for bee vectoring in the EU.
    • Vegetable production in Spain reached about 16.39 million tons in 2021, an increase of about 1.21 million tons over 2020.

    Royalty Pharma Reports Q4 and Full Year 2023 Results

    Retrieved on: 
    Thursday, February 15, 2024
    MorphoSys, Pfizer, European Commission, Recurrence, Docetaxel, Roche, Cystic fibrosis, Share repurchase, FDA, Food, Schizophrenia, Growth, Sacituzumab govitecan, PTC, Vertex, Astellas Pharma, Risdiplam, Metastasis, Projection, KarXT, Bristol Myers Squibb, PTC Therapeutics, Endocrine gland, Lung cancer, Civil service commission, JAK, Therapy, Tourette syndrome, Webcast, Patient, Cytokinetics, Eastern Time Zone, Novartis, Ruxolitinib, NDA, Pharmaceutical industry

    In October 2023, Royalty Pharma drew $350 million under its existing unsecured revolving credit facility, which was repaid during the fourth quarter of 2023.

    Key Points: 
    • In October 2023, Royalty Pharma drew $350 million under its existing unsecured revolving credit facility, which was repaid during the fourth quarter of 2023.
    • Royalty Pharma began repurchasing its Class A ordinary shares in April 2023 under a $1.0 billion multi-year share repurchase program.
    • During the fourth quarter of 2023, Royalty Pharma announced new transactions of up to $1.6 billion.
    • Royalty Pharma will host a conference call and simultaneous webcast to discuss its fourth quarter and full year 2023 results today at 8:00 a.m., Eastern Time.

    STX Group Announces Unique Financing Partnership With BioValue for Dutch Biomethane Plant

    Retrieved on: 
    Thursday, February 15, 2024
    European Commission, EBA, Partnership, Natural gas, European Parliament, CO2, STX Corporation, STX, REPowerEU, Renewable energy

    Amsterdam, Feb. 15, 2024 (GLOBE NEWSWIRE) -- STX Group , a leading global firm in environmental commodities trading and climate finance, today announces the financing partnership with BioValue , a major Dutch biomethane producer, for the construction and development of the Groengas Cothen biomethane plant.

    Key Points: 
    • Amsterdam, Feb. 15, 2024 (GLOBE NEWSWIRE) -- STX Group , a leading global firm in environmental commodities trading and climate finance, today announces the financing partnership with BioValue , a major Dutch biomethane producer, for the construction and development of the Groengas Cothen biomethane plant.
    • The financing by STX Group ensures BioValue access to key capital but also provides flexibility, avoiding potential constraints from fixed offtake prices.
    • Collaborating with Nationaal Groenfonds as the junior financier, STX Group goes beyond traditional offtake agreements: unlike traditional banking institutions, this financing model provides BioValue with exposure to the developing biomethane market, contributing to their strategic goals and long-term success.
    • "This agreement marks a significant milestone in the biomethane sector and showcases our ability to pioneer novel financing solutions," says Sead Keric, Managing Partner of Renewable Gas at STX Group.

    Piero Cipollone: Preserving people’s freedom to use a public means of payment: insights into the digital euro preparation phase

    Retrieved on: 
    Thursday, February 15, 2024
    Freedom, Fraud, European Parliament, General Data Protection Regulation, PayPal, The Economic Journal, Committee, Privacy, ATM, SPACE, Council, Remuneration, Communication, Digital currency, European Commission, Conclusion, Economy, Frankfurt, Central bank, Civil service commission, European Central Bank, News, Heart, Reproduction, Risk management, Thought, Letter, Public sector, Risk, European Payments Initiative, COM, Applicability, Element, Riau rupiah, ECB, Cryptocurrency

    Our approach relies on a term structure model of traded headline inflation-linked swap rates, which we assume span core inflation.

    Key Points: 
    • Our approach relies on a term structure model of traded headline inflation-linked swap rates, which we assume span core inflation.
    • The model provides estimates of market-based expectations for core inflation, as well as core inflation risk premia, at daily frequency, whereas core inflation expectations from surveys or macroeconomic projections are typically only available monthly or quarterly.

    Canada Strengthens Global Cooperation on Energy and Climate at 2024 IEA Ministerial

    Retrieved on: 
    Wednesday, February 14, 2024
    Lithium, Committee, IEA, Mining, Sustainability, Indigenous peoples, Transport, ESG, Government, Natural Resources, International Energy Agency, Biodiversity, Press release, Climate change, Paramount, History, Private sector, Gas, BNEF, Nuclear energy, Organization, Bloomberg L.P., Policy, Nuclear fusion, Legislation, European Commission, Recycling, Research, Methane, Wind, Renewable energy

    The IEA is the leading global intergovernmental organization that provides independent analysis, data and policy recommendations on the global energy sector.

    Key Points: 
    • The IEA is the leading global intergovernmental organization that provides independent analysis, data and policy recommendations on the global energy sector.
    • While at the IEA, Minister Wilkinson advanced the following priorities on behalf of the Government of Canada, all of which were reflected in the final IEA Ministerial Communique :
      1.
    • Implementing the Canada–US Memorandum of Understanding on Energy Cooperation, signed in June 2021, on sustainable and equitable energy transitions, clean energy innovation, connectivity and low-carbon transportation.
    • Canada is pleased to support the international energy and climate cooperation, research and programs of the IEA under the leadership of Dr.

    Trane Technologies, EU Parliament and Commission Officials & Cold Chain Partners Call for Accelerated Food Loss Solutions

    Retrieved on: 
    Wednesday, February 14, 2024
    Building Systems, Environmental, Social and Governance (ESG), Retail, Construction & Property, Sustainability, Manufacturing, Professional Services, Environment, Environmental Issues, Agriculture, Natural Resources, Other Manufacturing, Food, Beverage, HVAC, Other Construction & Property, Engineering, FoodDrinkEurope, European Commission, European, NGO, Multimedia, Partnership, Farmer, Table, Loss, Gigaton, Trane Technologies, Thermo King, Carbon, Schwarz Gruppe, Civil service commission, Unit, Associate, SAFE, Policy, MEP, Science Based Targets initiative, European Parliament, Food chain, Science, COPA-COGECA, Renewable energy

    Trane Technologies (NYSE:TT), a global climate innovator, co-developed a round table event at the European Parliament on Advancing Food Loss Technologies and Policies.

    Key Points: 
    • Trane Technologies (NYSE:TT), a global climate innovator, co-developed a round table event at the European Parliament on Advancing Food Loss Technologies and Policies.
    • View the full release here: https://www.businesswire.com/news/home/20240214416167/en/
      Trane Technologies co-developed a round table event at the European Parliament on Advancing Food Loss Technologies and Policies.
    • (Photo: Business Wire)
      “We are very proud to have partnered on this event with Competere, as well as working with members of the European Commission, European Parliament and major cold chain partners,” said Claudio Zanframundo, president, Thermo King EMEA, Trane Technologies.
    • Having an efficient and sustainable cold chain makes a big difference in reducing food waste and putting food on tables across the world.

    Options Abound as Europe’s ESG Services Expand Rapidly

    Retrieved on: 
    Wednesday, February 14, 2024
    Consulting, Data Management, Technology, Professional Services, Security, Software, Networks, Internet, Environment, Mobile, Wireless, Sustainability, Schneider Electric, Infosys, European Commission, ERM, NTT, FactSet, BCG, European Green Deal, Research, Bloomberg, Wipro, SAP, EY, IBM, ESG, Benchmarking, WSP, ISS, European, CDP, NTT DATA, CGI, Civil service commission, Accenture, S&P Global, LTIMindtree, Organization, Tech Mahindra, PwC, Sustainalytics, Managed services, RepRisk, Bain & Company, Trust, ISG, TCS, Research report, Renewable energy

    The 2023 ISG Provider Lens™ Sustainability and ESG report for Europe finds the global market for sustainability and ESG solutions and services is on track to expand from approximately €50 billion in 2022, to more than €100 billion by 2030.

    Key Points: 
    • The 2023 ISG Provider Lens™ Sustainability and ESG report for Europe finds the global market for sustainability and ESG solutions and services is on track to expand from approximately €50 billion in 2022, to more than €100 billion by 2030.
    • By 2026, more than 60 percent of EU companies will be required to begin externally reporting certain sustainability and ESG data in specific formats.
    • Because digital services will be critical to this transformation, portions of this funding will find their way to providers of those services, the ISG report says.
    • The 2023 ISG Provider Lens™ Sustainability and ESG report for Europe evaluates the capabilities of 106 providers across five quadrants: Strategy and Enablement Services, Technology Solutions and Implementation Services – IT, Technology Solutions and Implementation Services – OT, Data Platforms and Managed Services, and Rating and Benchmarking Services.

    European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)

    Retrieved on: 
    Tuesday, February 13, 2024
    Hospital, European Commission, CRISPR, Volatile organic compound, Gene, HSC, TDT, SCD, Vertex, CRISPR Therapeutics, European, CRSP, Civil service commission, Haematopoietic system, Therapy, Patient, Sickle cell disease

    ZUG, Switzerland and BOSTON, Feb. 13, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announced today that the European Commission has granted conditional marketing authorization to CASGEVY™ (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 gene edited therapy. CASGEVY is approved for the treatment of patients who are 12 years of age and older with severe sickle cell disease (SCD) characterized by recurrent vaso-occlusive crises (VOCs) or transfusion-dependent beta thalassemia (TDT), for whom hematopoietic stem cell (HSC) transplantation is appropriate and a human leukocyte antigen matched related HSC donor is not available.

    Key Points: 
    • “The approval by the European Commission is yet another important regulatory milestone underscoring the potentially transformative benefit of CASGEVY for patients with severe sickle cell disease and transfusion-dependent beta thalassemia,” said Samarth Kulkarni, Chairman and Chief Executive Officer of CRISPR Therapeutics.
    • Vertex is working closely with national health authorities in the European Union (EU) to secure access for eligible patients as quickly as possible.
    • Through this work, they have secured early access for eligible TDT patients in France ahead of the national reimbursement process.
    • There are currently three activated ATCs in the EU with plans to activate a total of approximately 25 centers across Europe.